TipRanks
Go Ultimate55% OFF

Compare aTyr Pharma (471A) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:471AaTyr PharmaEUR 0.23EUR 10.81M-0.20-99.21%NeutralUnlock the DE:471A analyst price target with TipRanks PremiumDE:471AUnlock the DE:471A top-analyst price target with TipRanks Premium
XBITXBiotech$1.88$57.32M-1.27-21.67%―Unlock the XBIT analyst price target with TipRanks PremiumDE:471A vs XBITUnlock the XBIT top-analyst price target with TipRanks Premium
PRLDPrelude Therapeutics$3.88$309.64M-4.91147.13%Moderate BuyUnlock the PRLD analyst price target with TipRanks PremiumDE:471A vs PRLDUnlock the PRLD top-analyst price target with TipRanks Premium
CNTXContext Therapeutics$0.19$17.37M-0.39-83.27%Strong BuyUnlock the CNTX analyst price target with TipRanks PremiumDE:471A vs CNTXUnlock the CNTX top-analyst price target with TipRanks Premium
OKYOOKYO Pharma Limited Sponsored ADR$1.47$77.14M-6.15-43.46%Moderate BuyUnlock the OKYO analyst price target with TipRanks PremiumDE:471A vs OKYOUnlock the OKYO top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:471AaTyr Pharma0.23-29.77-99.23%
XBITXBiotech1.88-0.41-17.90%
PRLDPrelude Therapeutics3.88-0.10-2.51%
CNTXContext Therapeutics0.19-0.89-82.50%
OKYOOKYO Pharma Limited Sponsored ADR1.47-1.23-45.56%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts